| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5767251 | EMD SERONO | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) | |
| US5767067 | EMD SERONO | Follicle stimulating hormone and pharmaceutical compositions containing same |
Jun, 2015
(8 years ago) | |
| US7563763 | EMD SERONO | FSH and FSH variant formulations, products and methods |
Aug, 2019
(4 years ago) | |
Gonal-F is owned by Emd Serono.
Gonal-F contains Follitropin Alfa/Beta.
Gonal-F has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Gonal-F are:
- US5767251
- US5767067
- US7563763
Gonal-F was authorised for market use on 25 March, 2004.
Gonal-F is available in injectable;subcutaneous dosage forms.
The generics of Gonal-F are possible to be released after 23 August, 2019.
Drugs and Companies using FOLLITROPIN ALFA/BETA ingredient
Market Authorisation Date: 25 March, 2004
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
GONAL-F family patents
